"Receive $2M upon 100 patients being enrolled in COUNTER trial no later than September 30, 2015 (“Term C Loan”)"
That means 60 additional patients have to be enrolled from now to September . About 20/month. Keep in mind company was only doing 13/month the last two quarters. This is why I expect price will continue uptrend with the pick up in enrollment